INTERNATIONAL PATENT: OVERT BIO, INC. FILES APPLICATION FOR "CANCER REACTIVE T CELL RECEPTORS"

GENEVA, Sept. 10 -- OVERT BIO, INC. (430 East 29th Street, 14th FloorNew York, New York 10016) filed a patent application (PCT/US2025/017340) for "CANCER REACTIVE T CELL RECEPTORS" on Feb 26, 2025. With publication no. WO/2025/184172, the details related to the patent application was published on Sep 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEGUT, Mateusz (c/o OverT Bio, Inc.430 East 29th Street, 14th FloorNew York, New York 10016), SANJANA, Neville E. (c/o OverT Bio, Inc.430 East 29th Street, 14th FloorNew York, New York 10016), ROBERTO, Mark P. (c/o OverT Bio, Inc.430 East 29th ...